亚洲队列中成神经管细胞瘤亚型的基因组景观。

IF 1.5 4区 医学 Q4 ONCOLOGY Translational cancer research Pub Date : 2024-12-31 Epub Date: 2024-12-18 DOI:10.21037/tcr-24-1350
Dongming Han, Xin Jin, Jiankang Li
{"title":"亚洲队列中成神经管细胞瘤亚型的基因组景观。","authors":"Dongming Han, Xin Jin, Jiankang Li","doi":"10.21037/tcr-24-1350","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Medulloblastoma (MB) is a highly malignant childhood brain tumor. Previous research on the genetic underpinnings of MB subtypes has predominantly focused on European and American cohorts. Given the notable genetic differences between Asian and other populations, a subtype-specific study on an Asian cohort is essential to provide comprehensive insights into MB within this demographic. The aim of this study is to investigate the genomic landscape of MB subtypes in an Asian cohort to better understand the genetic variations and potential implications for clinical practice.</p><p><strong>Methods: </strong>We conducted a study on an Asian cohort comprising 113 MB patients. Genomic sequencing was performed using MGISEQ-2000 platform. We analyzed the participants' characteristics and compared them with previous studies. All germline variants of the ten susceptibility genes of interest (<i>APC, BRCA2, PTCH1, PTCH2, ELP1, SUFU, CTNNB1, SMARCA4, GPR161</i>, and <i>TP53</i>) were annotated and validated.</p><p><strong>Results: </strong>Our study identified 14 valid germline variants that met our criteria, with these variants being detected in the genes <i>APC, BRCA2, PTCH1, PTCH2, ELP1</i>, and <i>SUFU</i>. Of these, six variants were classified as pathogenic in ClinVar: two in <i>PTCH2</i> (c.C1573T), one in <i>ELP1</i> (c.C583T), and three in <i>PTCH1</i> (c.G1370T, c.C2066T, c.C529T). The remaining eight variants were of uncertain significance, including those in <i>SUFU</i> (c.T833C), <i>ELP1</i> (c.T2A), <i>BRCA2</i> (c.G7488C), and <i>APC</i> (c.C3247A, c.A1G, c.A8042G, c.A3056G, c.G822C). Our findings highlight a subtype-based germline variant landscape specific to the Asian cohort and reinforce the connection between <i>SUFU</i>, <i>PTCH1</i>, and the SHH subtype of MB. Additionally, the identification of ELP1-related cases supports the newest findings in this area and provides typical copy number variation (CNV) results for future investigation.</p><p><strong>Conclusions: </strong>This study provides valuable insights into the genetic landscape of MB in an Asian cohort, emphasizing the importance of population-specific research. The subtype-specific germline variant landscape identified in this study contributes to the understanding of MB and its genetic underpinnings in Asian populations, potentially guiding future research and therapeutic strategies.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"13 12","pages":"6721-6731"},"PeriodicalIF":1.5000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11730696/pdf/","citationCount":"0","resultStr":"{\"title\":\"Genomic landscape of medulloblastoma subtypes in an Asian cohort.\",\"authors\":\"Dongming Han, Xin Jin, Jiankang Li\",\"doi\":\"10.21037/tcr-24-1350\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Medulloblastoma (MB) is a highly malignant childhood brain tumor. Previous research on the genetic underpinnings of MB subtypes has predominantly focused on European and American cohorts. Given the notable genetic differences between Asian and other populations, a subtype-specific study on an Asian cohort is essential to provide comprehensive insights into MB within this demographic. The aim of this study is to investigate the genomic landscape of MB subtypes in an Asian cohort to better understand the genetic variations and potential implications for clinical practice.</p><p><strong>Methods: </strong>We conducted a study on an Asian cohort comprising 113 MB patients. Genomic sequencing was performed using MGISEQ-2000 platform. We analyzed the participants' characteristics and compared them with previous studies. All germline variants of the ten susceptibility genes of interest (<i>APC, BRCA2, PTCH1, PTCH2, ELP1, SUFU, CTNNB1, SMARCA4, GPR161</i>, and <i>TP53</i>) were annotated and validated.</p><p><strong>Results: </strong>Our study identified 14 valid germline variants that met our criteria, with these variants being detected in the genes <i>APC, BRCA2, PTCH1, PTCH2, ELP1</i>, and <i>SUFU</i>. Of these, six variants were classified as pathogenic in ClinVar: two in <i>PTCH2</i> (c.C1573T), one in <i>ELP1</i> (c.C583T), and three in <i>PTCH1</i> (c.G1370T, c.C2066T, c.C529T). The remaining eight variants were of uncertain significance, including those in <i>SUFU</i> (c.T833C), <i>ELP1</i> (c.T2A), <i>BRCA2</i> (c.G7488C), and <i>APC</i> (c.C3247A, c.A1G, c.A8042G, c.A3056G, c.G822C). Our findings highlight a subtype-based germline variant landscape specific to the Asian cohort and reinforce the connection between <i>SUFU</i>, <i>PTCH1</i>, and the SHH subtype of MB. Additionally, the identification of ELP1-related cases supports the newest findings in this area and provides typical copy number variation (CNV) results for future investigation.</p><p><strong>Conclusions: </strong>This study provides valuable insights into the genetic landscape of MB in an Asian cohort, emphasizing the importance of population-specific research. The subtype-specific germline variant landscape identified in this study contributes to the understanding of MB and its genetic underpinnings in Asian populations, potentially guiding future research and therapeutic strategies.</p>\",\"PeriodicalId\":23216,\"journal\":{\"name\":\"Translational cancer research\",\"volume\":\"13 12\",\"pages\":\"6721-6731\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11730696/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational cancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21037/tcr-24-1350\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-24-1350","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/18 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:髓母细胞瘤是一种高度恶性的儿童脑肿瘤。先前对MB亚型遗传基础的研究主要集中在欧洲和美国的队列中。鉴于亚洲人和其他人群之间存在显著的遗传差异,对亚洲人群进行亚型特异性研究对于全面了解该人群中的MB至关重要。本研究的目的是研究亚洲队列中MB亚型的基因组景观,以更好地了解遗传变异及其对临床实践的潜在影响。方法:我们对113名MB患者进行了一项亚洲队列研究。使用MGISEQ-2000平台进行基因组测序。我们分析了参与者的特征,并与之前的研究进行了比较。对10个感兴趣的易感基因(APC、BRCA2、PTCH1、PTCH2、ELP1、SUFU、CTNNB1、SMARCA4、GPR161和TP53)的所有种系变异进行了注释和验证。结果:我们的研究确定了14个符合我们标准的有效种系变异,这些变异在APC、BRCA2、PTCH1、PTCH2、ELP1和SUFU基因中被检测到。其中,6个变异在ClinVar中被分类为致病性:2个在PTCH2中(c.C1573T), 1个在ELP1中(c.C583T), 3个在PTCH1中(c.G1370T, c.C2066T, c.C529T)。其余8个变异的意义不确定,包括SUFU (c.T833C)、ELP1 (c.T2A)、BRCA2 (c.G7488C)和APC (c.C3247A、c.A1G、c.A8042G、c.A3056G、c.G822C)。我们的研究结果强调了亚洲人群特有的基于亚型的种系变异景观,并加强了SUFU、PTCH1和MB的SHH亚型之间的联系。此外,elp1相关病例的鉴定支持了该领域的最新发现,并为未来的研究提供了典型的拷贝数变异(CNV)结果。结论:本研究为亚洲队列中MB的遗传景观提供了有价值的见解,强调了人群特异性研究的重要性。本研究确定的亚型特异性种系变异景观有助于了解MB及其在亚洲人群中的遗传基础,可能指导未来的研究和治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Genomic landscape of medulloblastoma subtypes in an Asian cohort.

Background: Medulloblastoma (MB) is a highly malignant childhood brain tumor. Previous research on the genetic underpinnings of MB subtypes has predominantly focused on European and American cohorts. Given the notable genetic differences between Asian and other populations, a subtype-specific study on an Asian cohort is essential to provide comprehensive insights into MB within this demographic. The aim of this study is to investigate the genomic landscape of MB subtypes in an Asian cohort to better understand the genetic variations and potential implications for clinical practice.

Methods: We conducted a study on an Asian cohort comprising 113 MB patients. Genomic sequencing was performed using MGISEQ-2000 platform. We analyzed the participants' characteristics and compared them with previous studies. All germline variants of the ten susceptibility genes of interest (APC, BRCA2, PTCH1, PTCH2, ELP1, SUFU, CTNNB1, SMARCA4, GPR161, and TP53) were annotated and validated.

Results: Our study identified 14 valid germline variants that met our criteria, with these variants being detected in the genes APC, BRCA2, PTCH1, PTCH2, ELP1, and SUFU. Of these, six variants were classified as pathogenic in ClinVar: two in PTCH2 (c.C1573T), one in ELP1 (c.C583T), and three in PTCH1 (c.G1370T, c.C2066T, c.C529T). The remaining eight variants were of uncertain significance, including those in SUFU (c.T833C), ELP1 (c.T2A), BRCA2 (c.G7488C), and APC (c.C3247A, c.A1G, c.A8042G, c.A3056G, c.G822C). Our findings highlight a subtype-based germline variant landscape specific to the Asian cohort and reinforce the connection between SUFU, PTCH1, and the SHH subtype of MB. Additionally, the identification of ELP1-related cases supports the newest findings in this area and provides typical copy number variation (CNV) results for future investigation.

Conclusions: This study provides valuable insights into the genetic landscape of MB in an Asian cohort, emphasizing the importance of population-specific research. The subtype-specific germline variant landscape identified in this study contributes to the understanding of MB and its genetic underpinnings in Asian populations, potentially guiding future research and therapeutic strategies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
252
期刊介绍: Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
期刊最新文献
Safety and efficacy of mecapegfilgrastim in preventing neutropenia in patients with head and neck cancer: a multicenter, prospective, observational, real-world study. Slamming hepatocellular carcinoma: targeting immunosuppressive macrophages via SLAMF7 reprograms the tumor microenvironment. Targeting the EZH2-SLFN11 pathway-a lesson in developing molecularly-informed treatments for recurrent small cell lung cancer. The clinicopathological significance of BRI3BP in women with invasive breast cancer. Treatment of immune checkpoint inhibitor-related colitis: a narrative review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1